Cetirizine vs Diphenhydramine for Pediatric Allergic Rhinitis
Critical Safety Warning About Diphenhydramine
- The American Academy of Pediatrics recommends against using over-the-counter cough and cold medications containing first-generation antihistamines, such as diphenhydramine, in children under 6 years of age due to significant safety concerns, including documented fatalities 1, 2.
- Between 1969-2006, there were 69 deaths associated with antihistamines in children under 6 years, with diphenhydramine responsible for 33 of these fatalities, highlighting the need for caution with first-generation antihistamines in young children 3, 4.
Why Cetirizine is the Preferred Choice
- The American Academy of Pediatrics and the FDA recommend second-generation antihistamines, such as cetirizine, over first-generation antihistamines for the treatment of allergic rhinitis in children under 6 years of age, due to their better safety profile and efficacy 1, 2.
- Cetirizine can be dosed at 2.5 mg once or twice daily in children aged 2-5 years, providing effective symptom relief with minimal sedation risk, and is one of only two antihistamines with FDA approval for children under 5 years 1, 2.
Practical Dosing and Administration
- Liquid formulations of cetirizine are preferred in young children due to easier administration and better absorption, and the medication has been shown to be well-tolerated with a good safety profile in this age group 4.
- While cetirizine may cause some sedation at recommended doses, this effect is significantly less than first-generation antihistamines and is dose-related, according to the Journal of Allergy and Clinical Immunology 1, 2.
Additional Clinical Benefits of Cetirizine
- In children with atopic dermatitis sensitized to allergens, cetirizine provides benefits beyond skin symptoms and reduces the risk of asthma development, as reported by the American Academy of Pediatrics 5.
Common Pitfalls to Avoid
- The FDA explicitly contraindicates using diphenhydramine "to make a child sleepy" due to the risk of adverse effects, and physicians must ensure patients understand the potential risks and benefits of antihistamine use in pediatric patients 1, 2.
- The American Academy of Pediatrics recommends avoiding the combination of cetirizine with other sedating medications without considering additive CNS effects, to minimize the risk of adverse events 5.
When Intranasal Corticosteroids May Be Preferred
- For more persistent or severe allergic rhinitis symptoms, intranasal corticosteroids are the most effective medication class and should be considered as first-line treatment, with second-generation antihistamines as second-line, according to the American Academy of Allergy, Asthma, and Immunology 3.